Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

AtriCure, Inc. (ATRC)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
65.44-1.49 (-2.23%)
At close: 04:00PM EST
65.44 0.00 (0.00%)
After hours: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close66.93
Open66.10
Bid0.00 x 1300
Ask72.50 x 800
Day's Range63.17 - 66.71
52 Week Range55.77 - 89.18
Volume194,807
Avg. Volume257,368
Market Cap3.006B
Beta (5Y Monthly)1.14
PE Ratio (TTM)65.90
EPS (TTM)0.99
Earnings DateFeb 21, 2022 - Feb 25, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est99.00
  • Insider Monkey

    AtriCure Inc. (ATRC) Fell Out Of Favor With Hedge Funds?

    While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors are starting to get cautious towards the current bull run since March, 2020 and hedging or reducing many of their long positions. Some fund managers are betting on Dow […]

  • Business Wire

    AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2021, Provides Financial Outlook for 2022

    MASON, Ohio, January 10, 2022--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, announced preliminary financial results for the fourth quarter and full year 2021 and provided 2022 financial guidance.

  • Business Wire

    AtriCure to Participate in the 40th Annual J.P. Morgan Healthcare Conference

    MASON, Ohio, December 20, 2021--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming 40th Annual J.P. Morgan Healthcare Conference.

Advertisement
Advertisement